M K Proteins Ltd

M. K. Proteins Limited announced that shareholders approved the appointment of Ms. Aritika Garg (DIN: 11895058) as an Independent Director for a term of five years with effect from August 22, 2026, at the company’s 14th Annual General Meeting held on September 30, 2026.

M. K. Proteins Limited will close its trading window for all employees, directors, key managerial personnel, promoters, designated persons and their immediate relatives or any other insider from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the second quarter and half year ended September 30, 2026, in accordance with SEBI regulations.

M K Proteins Limited informed the Bombay Stock Exchange and National Stock Exchange of India that its Register of Members and Share Transfer Books will remain closed from September 24, 2026, to September 30, 2026, for the purpose of holding its 14th Annual General Meeting scheduled for September 30, 2026, at 11:00 A.M., and that September 23, 2026, has been set as the record date for electronic voting eligibility.

M K Proteins Limited informed the Bombay Stock Exchange and National Stock Exchange of India that its Register of Members and Share Transfer Books will remain closed from September 24, 2026, to September 30, 2026, for the purpose of holding its 14th Annual General Meeting scheduled for September 30, 2026, at 11:00 A.M., and that September 23, 2026, has been set as the record date for determining shareholders eligible to vote electronically.

M. K. Proteins Limited announced that its Board of Directors approved the notice of the 14th Annual General Meeting and the Directors Report, scheduling the meeting for Wednesday, September 30, 2026, at 11:00 A.M. through VC/OAVM, and declared a book closure from September 24, 2026, to September 30, 2026, for the purpose of holding the AGM.

M. K. Proteins Limited will hold a board meeting on Thursday, August 13, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026, according to a regulatory filing with the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.

Net profit of M K Proteins declined 59.29% to Rs 1.14 crore in the quarter ended March 2026 as against Rs 2.80 crore during the previous quarter ended March 2025. Sales rose 6.37% to Rs 145.94 crore in the quarter ended March 2026 as against Rs 137.20 crore during the previous quarter ended March 2025. For the full year,net profit declined 18.69% to Rs 6.83 crore in the year ended March 2026 as against Rs 8.40 crore during the previous year ended March 2025. Sales rose 43.02% to Rs 382.88 crore in the year ended March 2026 as against Rs 267.71 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales145.94137.20 6 382.88267.71 43 OPM %1.713.40 -2.984.65 - PBDT1.834.01 -54 9.8311.81 -17 PBT1.723.92 -56 9.3911.46 -18 NP1.142.80 -59 6.838.40 -19 Powered by Capital Market - Live

M K Proteins will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of M K Proteins rose 3.62% to Rs 1.43 crore in the quarter ended December 2025 as against Rs 1.38 crore during the previous quarter ended December 2024. Sales rose 126.85% to Rs 89.56 crore in the quarter ended December 2025 as against Rs 39.48 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales89.5639.48 127 OPM %2.644.53 - PBDT2.081.97 6 PBT1.961.86 5 NP1.431.38 4 Powered by Capital Market - Live

M K Proteins will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live